Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“This is simply a blood draw.” Analyzing plasma to define gene mutations in breast cancer is less invasive than tissue biopsies.
Researchers developed a new tool, the EPIC-seq, that can diagnose cancer subtypes from patient blood samples.
An Army veteran, retired firefighter and farmer, Jeff Meckstroth, 65, lives in Ohio. He has Stage IV metastatic non-small-cell lung cancer.
Researchers identified 128 PSA-associated genetic variants, including 82 new ones, which they used to build a risk score.
Upon reflecting on his testicular cancer experience, Gaurav Udiyavar wants to spread more awareness.
New diagnoses of bladder, colorectal, lung and prostate cancer fell during the spring of 2020 and did not return to previous levels.
Genevieve and I have certainly had our hands full for the past few weeks. But now things are on the upswing.
Thank you for all your prayers and positive thoughts—we got the result we were hoping for.
A new FDA-approved imaging technique for prostate cancer locates cancer lesions in the pelvic area to which the tumors have migrated.
A diagnosis of benign prostatic hyperplasia could protect against prostate cancer development.
Just when it seemed like all of my treatment options were nasty and not very promising, things are looking up!
It looks like we dodged another bullet. The fun never stops, does it?
A former world champion triathlete, Siri Lindley, 52, lives with her wife in Longmont, Colorado. She was treated for acute myeloid leukemia.
The genetic variant frequently causes low white blood cell counts in African Americans who are otherwise healthy.
Seeding—the transfer of tumor cells from a dislodged biopsy needle—is not impossible but very rare.
A new nasal swab test may help identify which people with lung nodules are at most risk for lung cancer and require a biopsy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.